March 7, 2024American Journal of HematologyOpen Access

Changing hemostatic management in post‐partum hemorrhage

View Full Paper

Ask AI

Bookmark

Authors

ARA. RigouzzoSorbonne Université PFPierre‐Antoine FroissantHôpital Beaujon NLNicolas LouvetSorbonne Université

Discussion

Member takes

Implication

Clinical review demonstrates point-of-care viscoelastic assays detect hypofibrinogenemia in postpartum hemorrhage, highlighting the utility of targeted fibrinogen replacement.

Key Points

Fibrinogen decrease occurs earlier than other coagulation factor deficiencies, making hypofibrinogenemia an early marker of postpartum hemorrhage progression.
Clinical evaluation indicates point-of-care viscoelastic hemostatic assays rapidly assess coagulopathy, enabling targeted fibrinogen replacement during severe bleeding.
Adopting viscoelastic hemostatic assays supports early characterization of coagulopathy, yet further studies must establish thresholds for remaining coagulation factors.

Cite This Study

Rigouzzo et al. (2024) studied this question.

synapsesocial.com/papers/68e75433b6db6435876cc3b8 https://doi.org/10.1002/ajh.27264

View Full Paper

Ask AI

Bookmark

Implication

Clinical review demonstrates point-of-care viscoelastic assays detect hypofibrinogenemia in postpartum hemorrhage, highlighting the utility of targeted fibrinogen replacement.

Changing hemostatic management in post‐partum hemorrhage

Discussion

Member takes

Implication

Key Points

Cite This Study

Changing hemostatic management in post‐partum hemorrhage

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider